MET and lung carcinoma: Genistein was shown to inhibit lung cancer cell proliferation by using an anticancer mechanism that activates the caspase 3/9 signaling pathway to induce lung cancer cell apoptosis while activating the expression of miR-27, an activator of Wnt signaling pathway, and reducing the expression of the MET protein, a receptor of lung cancer cell growth factor [160].